GlassScriptPhysician profile
Charles Gordon Lampley
NPI 1477530608
$780.56
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $149 · 2020: $11.46 · 2021: $143 · 2022: $222 · 2023: $228 · 2024: $26.97.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $255.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $255.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $369.56 | 2019-2023 | |
| Myovant Sciences INC. | $92.26 | 2022 | |
| Mylan Pharmaceuticals INC. | $83.72 | 2021-2022 | |
| Pfizer INC. | $82.53 | 2022-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $53.70 | 2022-2023 | |
| Organon LLC | $48.22 | 2022-2024 | Nexplanon |
| Hologic Sales and Service, LLC | $37.50 | 2023 | Acessa Provu System, Coolseal Generator, Fluent Fluid Management System |
| Merck Sharp & Dohme LLC | $13.07 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Lampley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.